Key facts
- It has raised $2.6M; the latest was Seed Round in Feb 2025.
- Notable investors include Gaingels, Team Ignite Ventures, Village Global, Lightbank (Venture Capital), JHH vc — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Halo Cures
- ·The full record, as it builds
Funding rounds
No funding rounds for Halo Cures are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Halo Cures
Operator of a collaboration platform intended to rate and review proposals collectively with small and medium enterprises and track their status in pipelines. The company uses an RFP process that connects companies directly with scientists from universities and startups, enabling corporations in healthcare, technology, chemicals, and the consumer goods sector to solve important business challenges.
- Sector
- Business Products and Services (B2B)
- HQ
- Chicago, IL, United States
- Founded
- 2016
- Employees
- 10
- Website
- halo.science/
- Ownership
- Privately Held (backing)
Halo Cures doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Halo Cures shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Halo Cures in its N-PORT filings yet. We sweep new filings monthly.